Skip to main content

Month: February 2026

Philips proposes to re-appoint CEO Roy Jakobs

Roy Jakobs, CEO Royal PhilipsRoy Jakobs, CEO Royal PhilipsFebruary 10, 2026 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that Roy Jakobs is proposed to be re-appointed as its President/Chief Executive Officer and member of the Board of Management. The decision to propose the re-appointment of Roy Jakobs reflects the Supervisory Board’s recognition of the progress made since 2022 and its confidence in his leadership as Philips enters the next phase of driving profitable growth. The proposal will be submitted for approval at the upcoming Annual General Meeting of Shareholders (AGM), to be held on May 8, 2026. “Roy Jakobs has demonstrated clear leadership, strong execution and a relentless focus on strengthening Philips amid an uncertain macro environment,”...

Continue reading

SalMar – Strong operational performance with record‑high harvest volume and lower cost level

With a lower cost level in the value chain and rising market prices, the result for the fourth quarter increased significantly compared with earlier quarters in 2025 and same quarter in 2024. In 2025, SalMar also reached a milestone where the Group, including associated companies, for the first time exceeded 300,000 tonnes harvested in a single year (300,900 tonnes). Operational EBIT for Norway was NOK 1,843 million in the fourth quarter of 2025. The harvest volume was 80,300 tonnes, and operational EBIT per kg was NOK 23.0. For the Group, operational EBIT was NOK 1,834 million in the fourth quarter of 2025. The harvest volume was 84,100 tonnes, and operational EBIT per kg was NOK 21.8. Continued strong operational and biological performance in Norway, with lower costs in the value chain. Reduced contribution from Sales & Industry...

Continue reading

Announcement of Receipt of Notice From Nasdaq Regarding Minimum Bid Price Requirement

BUKIT MERTAJAM, MALAYSIA, Feb. 10, 2026 (GLOBE NEWSWIRE) — CCH Holdings Ltd (the “Company”), today announced that it received a notification letter, dated February 3, 2026 (the “Notification Letter “), from the Listing Qualifications Department of The Nasdaq Stock Market Inc. (the “Nasdaq”), notifying the Company that it is not in compliance with the requirement to maintain a minimum closing bid price of $1.00 per share, because the closing bid price of the Company’s ordinary shares was below $1.00 per share for 30 consecutive business days. The letters are only a notification of deficiency, not of imminent delisting, and have no current effect on the listing or trading of the Company’s securities on Nasdaq. The Company would like to clarify that the Notification Letters has no current effect...

Continue reading

Apollo Names Diego De Giorgi as Incoming Head of EMEA

LONDON and NEW YORK, Feb. 10, 2026 (GLOBE NEWSWIRE) — Apollo (NYSE: APO) today announced that industry veteran Diego De Giorgi will join the firm as a Partner and Head of EMEA. De Giorgi will succeed longtime Apollo Partner Rob Seminara in the role, who will remain in the region to support a successful transition before assuming new, global responsibilities for Apollo later this year. De Giorgi has spent more than 30 years in London serving in key leadership positions for large global banks. As Apollo’s Head of EMEA, De Giorgi will oversee a fast-growing region for the firm as it expands credit, equity and hybrid origination, as well as in wealth and retirement solutions. De Giorgi will work closely with Apollo’s senior investment leaders in Europe in addition to its global and regional management teams. “Having invested in EMEA...

Continue reading

FTI Consulting Builds Healthcare Advisory Capability in the Middle East With Addition of Two Senior Hires to Strategy & Transformation Practice

RIYADH, Saudi Arabia, Feb. 09, 2026 (GLOBE NEWSWIRE) — FTI Consulting, Inc. (NYSE: FCN) today announced the expansion of its Strategy & Transformation practice in the Middle East with the appointment of healthcare experts Oussama Nicolas and Tara Makarem as Senior Managing Directors in the firm’s Corporate Finance & Restructuring segment. In their role at the firm, Mr. Nicolas and Ms. Makarem will co-lead the firm’s new healthcare and life sciences offering, supporting clients across the public and private sectors in the United Arab Emirates, Kingdom of Saudi Arabia and Qatar. “Oussama and Tara bring deep sector expertise, strong leadership credentials and a proven track record of delivering complex healthcare transformations,” said Antoine Nasr, a Senior Managing Director and Head of FTI Consulting Middle East. “Under...

Continue reading

Fangzhou ’XingShi’ Large Language Model Highlighted Among China’s Most Anticipated Healthcare Models for 2026

SHANGHAI, Feb. 10, 2026 (GLOBE NEWSWIRE) — Industry research platform VBData recently highlighted “XingShi” Large Language Model (“XS LLM”) from Fangzhou Inc. (“Fangzhou” or the “Company”) (HKEX: 06086), a leader in AI-driven Internet healthcare solutions, as one of China’s most anticipated healthcare AI models for 2026. The “XingShi” Large Language Model (“XS LLM”) integrates five intelligent agents — knowledge services, triage, pre-consultation, physician support and electronic medical records — into a closed-loop system covering the full chronic disease management cycle, an approach that has drawn international attention including coverage by Nature. As one of the earliest domestic models developed alongside the emergence of OpenEvidence, XS LLM is powered by more than 1.1 million articles from over 170...

Continue reading

Neo-Concept International Group Holdings Limited Announces Pricing of Approximately US$8.1 Million Public Offering of Class A Ordinary Shares

Hong Kong, Feb. 09, 2026 (GLOBE NEWSWIRE) — Neo-Concept International Group Holdings Limited (Nasdaq: NCI) (the “Company”), a one-stop apparel solution services provider, today announced the pricing of its public offering on February 9, 2026 of 14,850,000 Class A ordinary shares at a public offering price of $0.5454 per Class A ordinary share (the “Offering”). Gross proceeds, before deducting placement agent fees and other offering expenses, are expected to be approximately $8.1 million. The offering is expected to close on February 11, 2025, subject to customary closing conditions. The Company intends to utilize the net proceeds from the Offering for expanding its business and for general working capital. D. Boral Capital LLC is acting as the lead placement agent and uSmart Securities Limited is acting as joint placement agent...

Continue reading

Iveda Announces Pricing of $2 Million Public Offering

MESA, Ariz., Feb. 09, 2026 (GLOBE NEWSWIRE) — Iveda® (Nasdaq: IVDA), the global leader in AI video surveillance and smart city solutions, today announced the pricing of a public offering of 5,714,286 shares of its common stock (or pre-funded warrants in lieu thereof) and series X warrants to purchase up to 11,428,572 shares of its common stock, at a combined public offering price of $0.35 per share (or pre-funded warrant in lieu thereof) and accompanying series X warrants. The series X warrants will have an exercise price of $0.35 per share, will be exercisable immediately upon issuance and will expire two years from the date of issuance. The closing of the offering is expected to occur on or about February 11, 2026, subject to the satisfaction of customary closing conditions. H.C. Wainwright & Co. is acting as the exclusive...

Continue reading

Spring Valley Acquisition Corp. IV Announces Pricing of $200 Million Initial Public Offering

DALLAS, Feb. 09, 2026 (GLOBE NEWSWIRE) — Spring Valley Acquisition Corp. IV (the “Company”), a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, announced the pricing of its initial public offering of 20,000,000 units at a price of $10.00 per unit on February 9, 2026. The units are expected to be listed for trading on the Nasdaq Global Market under the ticker symbol “SVIVU” beginning February 10, 2026. Each unit consists of one Class A ordinary share and one-fourth of one redeemable warrant of the Company. Each whole warrant entitles the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share, subject to certain adjustments. Once the securities comprising the...

Continue reading

ScanTech AI Systems Inc. Announces Nasdaq Delisting Determination, Pending Trading Suspension, and Intent to Seek OTCQB Quotation

Atlanta, GA, Feb. 09, 2026 (GLOBE NEWSWIRE) — ScanTech AI Systems Inc. (the “Company” or “ScanTech AI”) (Nasdaq: STAI),  a developer of advanced AI-powered security screening and imaging technologies, today provided an update regarding recent correspondence received from The Nasdaq Stock Market LLC (“Nasdaq”) related to the Company’s continued listing status. On February 4, 2026, the Company received a deficiency notice from Nasdaq’s Listing Qualifications Department indicating that, based on Nasdaq’s review of the Company’s market value of publicly held shares (“MVPHS”) for the 30 consecutive business days ended February 3, 2026, the Company did not meet the minimum MVPHS requirement of $15 million under Nasdaq Listing Rule 5450(b)(2)(C). In accordance with Nasdaq rules, the Company has a 180-day compliance...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.